Actions

Extra: Difference between revisions

From haematologyetc.co.uk

No edit summary
No edit summary
Line 1: Line 1:
HLA-DR
HLA-DR


:HLA-DR is considered a pan-B lineage  marker in leukaemia, although its widespread expression limits its value.
:HLA-DR is considered a pan-B lineage  marker in leukaemia and in cases where lineage is ambiguous the expression of HLA-DR may contribute to (but not prove) the assignment of B cell lineage. The molecule is also expressed by myeloid blasts, but rarely by promyelocytes so has value in identification of acute promyelocytic leukaemia (APL).
:Where lineage is ambiguous the expression of HLA-DR may contribute to the assignment of B cell lineage
:In myeloid leukaemias the absence of HLA-DR can have value in identification of acute promyelocytic leukaemia (APL)


details   
details   
HLA-DR is typically expressed by macrophages b-cells and dendritic cells. HLA-DR presents antigen to t-helper cells serving to suppress t-helper cell responses and prevent the production of antibodies against self-antigens. HLA-DR is also expressed by early myeloid progenitor cells but expression is lost as they mature to promyelocytes.  
HLA-DR presents antigen to T-helper cells and is typically expressed by cells involved in antigen processing and recognition - including macrophages, B-cells and dendritic cells. HLA-DR is also expressed by early myeloid progenitor cells but expression is lost as they mature to promyelocytes.  


*Myeloid leukaemias generally express HLA-DR but expression is expected to be absent from mature myeloid leukaemias such a APL and erythroid leukaemia  
Use
*In B-lineage leukaemias and lymphomas each will usually express HLA-DR, although expression is generally lost at the plasma cell stage
*Acute myeloid leukaemias generally express HLA-DR, but expression is expected to be absent from mature myeloid leukaemias such a APL and erythroid leukaemia  
*B-lineage leukaemias and lymphomas each will usually express HLA-DR, although expression is generally lost as they mature to plasma cells
*T-lineage ALL is generally HLA-DR negative, although rarely mature T-cell neoplasms may express HLA-DR
*T-lineage ALL is generally HLA-DR negative, although rarely mature T-cell neoplasms may express HLA-DR

Revision as of 18:33, 16 May 2023

HLA-DR

HLA-DR is considered a pan-B lineage marker in leukaemia and in cases where lineage is ambiguous the expression of HLA-DR may contribute to (but not prove) the assignment of B cell lineage. The molecule is also expressed by myeloid blasts, but rarely by promyelocytes so has value in identification of acute promyelocytic leukaemia (APL).

details HLA-DR presents antigen to T-helper cells and is typically expressed by cells involved in antigen processing and recognition - including macrophages, B-cells and dendritic cells. HLA-DR is also expressed by early myeloid progenitor cells but expression is lost as they mature to promyelocytes.

Use

  • Acute myeloid leukaemias generally express HLA-DR, but expression is expected to be absent from mature myeloid leukaemias such a APL and erythroid leukaemia
  • B-lineage leukaemias and lymphomas each will usually express HLA-DR, although expression is generally lost as they mature to plasma cells
  • T-lineage ALL is generally HLA-DR negative, although rarely mature T-cell neoplasms may express HLA-DR